Device manufacturer, as written on reports
Mpri: medical device reports filed with FDA
293,091 reports name it as the manufacturer of the device involved, 2007–2025.
- 293,091
- reports naming it as manufacturer
- 1.1% of all MAUDE reports
- 0
- reports, 12 months to August 2026
- 28,636 in the 12 months before
- 41.7%
- classified as malfunction
- 62.3% across all reports
- 1.8%
- classified as death, as reported
- 0.9% across all reports
293,091 medical device reports received by FDA give Mpri as the manufacturer of the device involved, 1.1% of the MAUDE database, from May 2007 to July 2025. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
0 reports arrived in the 12 months to August 2026, against 28,636 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (56.4%), malfunction (41.7%) and death (1.8%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| CapSureFix Novus Lead MRI SureScan | Permanent pacemaker electrode | 72,790 | 17,554 | 1% |
| Capsurefix Novus | Permanent pacemaker electrode | 37,142 | 4 | 6.8% |
| Sprint Quattro Secure S MRI SureScan | Implantable cardioverter defibrillator (non-crt) | 24,513 | 6,436 | 1.4% |
| SelectSecure MRI SureScan | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 14,405 | 4,994 | 1.3% |
| Sprint Quattro Secure | Implantable cardioverter defibrillator (non-crt) | 13,809 | 2 | 5.2% |
| CapSureFix Novus MRI SureScan | Permanent pacemaker electrode | 13,601 | 3,243 | 1.3% |
| Sprint Quattro Secure MRI SureScan | Implantable cardioverter defibrillator (non-crt) | 12,553 | 1,903 | 1.4% |
| Sprint Quattro Secure S | Implantable cardioverter defibrillator (non-crt) | 11,289 | 0 | 2.4% |
| Sprint Fidelis | Implantable cardioverter defibrillator (non-crt) | 6,938 | 340 | 14.1% |
| CapSure Fix MRI | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 4,622 | 600 | 0.6% |
| CapSure Sense Lead MRI SureScan | Permanent pacemaker electrode | 4,578 | 1,337 | 1% |
| Capsurefix Mri Surescan | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 3,994 | 0 | 2.8% |
| Attain Performa | Drug eluting permanent left ventricular (lv) pacemaker electrode | 3,960 | 0 | 1.8% |
| Attain Performa MRI SureScan | Drug eluting permanent left ventricular (lv) pacemaker electrode | 3,919 | 647 | 1.4% |
| CapSure SP | Permanent pacemaker electrode | 3,587 | 226 | 3.9% |
| Capsurefix | Permanent pacemaker electrode | 3,434 | 0 | 6.3% |
| Sprint Quattro | Implantable cardioverter defibrillator (non-crt) | 3,141 | 0 | 2.6% |
| Attain Otw | Permanent pacemaker electrode | 3,129 | 0 | 9.1% |
| Attain Stability Quad MRI SureScan | Drug eluting permanent left ventricular (lv) pacemaker electrode | 3,037 | 837 | 1.3% |
| Attain Performa S MRI SureScan | Drug eluting permanent left ventricular (lv) pacemaker electrode | 2,576 | 440 | 1.6% |
| CapSure Epicardial Lead | Permanent pacemaker electrode | 2,496 | 760 | 1.5% |
| Attain Ability | Drug eluting permanent left ventricular (lv) pacemaker electrode | 2,443 | 0 | 4.4% |
| Capsure Sp Novus | Permanent pacemaker electrode | 2,409 | 0 | 9.5% |
| Selectsecure | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 2,405 | 0 | 0.9% |
| CapSureFix Lead | Permanent pacemaker electrode | 2,372 | 358 | 0.8% |
| Capsure Sense | Permanent pacemaker electrode | 2,333 | 0 | 6.4% |
| CapSure SP Novus Lead | Permanent pacemaker electrode | 2,169 | 331 | 1.1% |
| Sprint | Implantable cardioverter defibrillator (non-crt) | 2,063 | 161 | 2.4% |
| CapSure Z Novus Lead | Permanent pacemaker electrode | 1,735 | 313 | 0.4% |
| Attain Performa Straight MRI SureScan | Drug eluting permanent left ventricular (lv) pacemaker electrode | 1,686 | 271 | 1.7% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| DTB | Permanent pacemaker electrode | 154,752 | 52.8% |
| LWS | Implantable cardioverter defibrillator (non-crt) | 67,400 | 23% |
| NVN | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 28,511 | 9.7% |
| OJX | Drug eluting permanent left ventricular (lv) pacemaker electrode | 23,210 | 7.9% |
| NVY | Permanent defibrillator electrodes | 10,416 | 3.6% |
| LWP | Implantable pulse generator, pacemaker (non-crt) | 4,875 | 1.7% |
| MHY | Stimulator, electrical, implanted, for parkinsonian tremor | 1,294 | 0.4% |
| LGW | Stimulator, spinal-cord, totally implanted for pain relief | 833 | 0.3% |
| OAE | Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation | 578 | 0.2% |
| EZW | Stimulator, electrical, implantable, for incontinence | 450 | 0.2% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Mpri reports
How many FDA device reports name Mpri as manufacturer?
293,091 reports through August 2026, 0 of them in the latest 12 months.
Which of its brands appear most often?
CapSureFix Novus Lead MRI SureScan (72,790), Capsurefix Novus (37,142), Sprint Quattro Secure S MRI SureScan (24,513), SelectSecure MRI SureScan (14,405) and Sprint Quattro Secure (13,809).
Which device types does it report on?
permanent pacemaker electrode (52.8%), implantable cardioverter defibrillator (non-crt) (23%), drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes (9.7%) and drug eluting permanent left ventricular (lv) pacemaker electrode (7.9%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.